Bacteria subverts immune response to aid infection

April 26, 2012

Listeria, one of the most deadly causes of bacterial food poisoning, subverts a normally protective immune response to spread its infection more effectively, according to new research at National Jewish Health. Immunologists Laurel Lenz, PhD, Peter Henson, PhD, and their colleagues report online April 26, 2012, in the journal Immunity that production of nitric oxide (NO) by activated macrophages, which is normally thought of as an infection-fighting response, actually helps Listeria monocytogenes to more efficiently disseminate between infected and neighboring uninfected cells.

"In the course of evolution, and their hosts engage in an ongoing arms race, responding to and countering each other's tactics to gain the upper hand," said Dr. Lenz. "In this case, Listeria has learned to evade a response that is normally protective and to do so in a way that substantially increases the spread of infection. Several other pathogens, including Rickettsia, Burkholderia, Vaccinia and HIV, spread throughout the host in a similar manner and may use similar strategies."

When Listeria or other pathogens first enter the body, on recognize general features of the pathogen and sound an early alarm that activates the . When activated, and other innate can more readily prevent free-floating pathogens from surviving upon entering cells. However, these activated cells also release of nitric oxide (NO), an important signaling molecule that triggers several defense mechanisms.

Dr. Lenz and his colleagues found that production of NO by activated cells helped to increase Listeria spread directly from cell to cell and replicate in its host. When Listeria spreads directly from cell to cell, it produces small buds on the surface of an infected cell. Neighboring cells that touch the infected cell absorb the buds containing the Listeria. Thus, the bacteria are transferred without ever entering the extracellular environment. The absorbed Listeria are initially contained within small bubbles, known as a vacuoles or phagosomes. Normally when a white blood cell absorbs a particle or organism, these phagosomes are targeted by a sort of cellular Death Star that fuses with them and destroys their contents. NO, however, delays the attack of these Death Stars, or lysosomes. This delay gives Listeria more time to escape the phagosome into the cell interior before it can be destroyed by the lysosomes.

"Delaying lysosome fusion with phagosomes tips the scale in favor of Listeria, allowing this pathogen to more effectively infect cells through cell-to-cell spread and thus to multiply in its host," said Dr. Lenz.

Explore further: Trudeau Institute reports new approach to treating Listeria infections

Related Stories

Trudeau Institute reports new approach to treating Listeria infections

October 17, 2011
Research underway at the Trudeau Institute could lead to new treatments for people sickened by Listeria and other sepsis-causing bacteria. Dr. Stephen Smiley's laboratory has published a study in the scientific journal Infection ...

Bacteria enter via mucus-making gut cells

October 3, 2011
Cells making slippery mucus provide a sticking point for disease-causing bacteria in the gut, according to a study published on October 3 in the Journal of Experimental Medicine.

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.